i
CDC recommends suspension of the routine use of the third and fourth doses of pneumococcal conjugate vaccine (Prevnar®)
-
03/02/2004
Details:
-
Journal Article:HAN
-
Corporate Authors:
-
Description:Tuesday, March 02, 2004, 16:26 EST (04:26 PM EST)
CDCHAN-00187-2004-03-02-ADV-N
All health-care providers should temporarily suspend routine use of both the third and fourth doses of pneumococcal conjugate vaccine (PCV7), the Centers for Disease Control and Prevention (CDC) recommended today. Children at increased risk of severe disease should continue to receive the full, routine, four-dose series.
CDC took the action in consultation with the American Academy of Family Physicians (AAFP), the American Academy of Pediatrics (AAP), and the Advisory Committee on Immunization Practices (ACIP), to most effectively use the limited, available doses of until the manufacturer can restore full production. Wyeth Vaccines, the sole manufacturer in the United States, markets PCV7 under the trade name Prevnar®.
-
Subjects:
-
Series:
-
Document Type:
-
Place as Subject:
-
Location:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
Supporting Files
-
No Additional Files
More +